Suppr超能文献

美国肾移植女性的避孕措施使用情况。

Contraceptive use among women with kidney transplants in the United States.

机构信息

Division of Nephrology, Kidney C.A.R.E. (Clinical Advancement, Research and Education) Program, University of Cincinnati, 231 Albert Sabin Way, MSB 6112, Cincinnati, OH, 45267, USA.

Department of Environmental Health, University of Cincinnati, Cincinnati, OH, USA.

出版信息

J Nephrol. 2022 Mar;35(2):629-638. doi: 10.1007/s40620-021-01181-0. Epub 2021 Nov 13.

Abstract

BACKGROUND

Kidney transplant improves reproductive function in women with end-stage kidney disease. Little is known about contraceptive use in women with history of kidney transplants.

METHODS

Using data from the United States Renal Data System, we evaluated for each calendar year women with kidney transplantation between 1/1/2005 and 12/31/2013 who were aged 15-44 years with Medicare as the primary payer and linked data from the United Network for Organ Sharing, for up to three entire years after the date of transplantation. We determined rates of contraceptive use and used multivariable logistic regression to identify factors associated with contraceptive use.

RESULTS

The study cohort included 13,150 women and represented 26,624 person-years. The rate of contraceptive use was 9.5%. Compared to women aged 15-24 years, contraceptive use was lower in women aged 30-34 years (OR 0.67; CI 0.58-0.78), 35-39 years (OR 0.36; CI 0.31-0.43), and 40-44 years (OR 0.23; CI 0.19-0.28). Compared to white women, contraceptive use was higher both in black women (OR 1.26; CI 1.10-1.43) and Native American women (OR 1.52; CI 1.02-2.26). Women had lower rates of contraceptive use in the second-year post-transplant (OR 0.87; CI 0.79-0.94) and the third-year post-transplant (OR0.69; CI 0.62-0.76) than in the first-year post-transplant. Women with a history of diabetes had a lower likelihood of contraceptive use (OR 0.80; CI 0.65-0.99).

CONCLUSION

Among women with kidney transplants, contraceptive use remains low at 9.5%. Factors associated with a higher likelihood of contraceptive use include younger age and black and Native American race/ethnicity; and second- and third-year post-transplant. The history of diabetes is associated with a lower likelihood of contraceptive use. The study highlights the need of increasing awareness for safe and effective contraceptive use in women with kidney transplants.

摘要

背景

肾移植可改善终末期肾病女性的生殖功能。对于有肾移植史的女性使用避孕措施的情况知之甚少。

方法

利用美国肾脏数据系统的数据,我们评估了 2005 年 1 月 1 日至 2013 年 12 月 31 日期间接受肾移植的年龄在 15-44 岁之间、主要支付者为医疗保险且与器官共享联合网络数据相匹配的女性,随访时间最长可达移植后 3 年。我们确定了避孕措施的使用率,并使用多变量逻辑回归来确定与避孕措施使用相关的因素。

结果

研究队列包括 13150 名女性,代表了 26624 人年。避孕措施使用率为 9.5%。与 15-24 岁的女性相比,30-34 岁(比值比[OR]0.67;95%置信区间[CI]0.58-0.78)、35-39 岁(OR 0.36;95%CI 0.31-0.43)和 40-44 岁(OR 0.23;95%CI 0.19-0.28)的女性避孕措施使用率较低。与白人女性相比,黑人(OR 1.26;95%CI 1.10-1.43)和美国原住民(OR 1.52;95%CI 1.02-2.26)女性的避孕措施使用率更高。与移植后第一年相比,移植后第二年(OR 0.87;95%CI 0.79-0.94)和第三年(OR 0.69;95%CI 0.62-0.76)女性的避孕措施使用率较低。有糖尿病史的女性使用避孕措施的可能性较低(OR 0.80;95%CI 0.65-0.99)。

结论

在肾移植女性中,避孕措施的使用率仍较低,为 9.5%。与避孕措施使用可能性增加相关的因素包括年龄较小、黑人和美国原住民种族/民族;以及移植后第二年和第三年。糖尿病史与避孕措施使用的可能性较低有关。该研究强调了需要提高对肾移植女性安全有效避孕措施使用的认识。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验